AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT05297695 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Triple therapy for H. pylori infection
Description: Triple therapy for H. pylori infection (Esomeprazole, Amoxicillin, and Clarithromycin) for two weeks
Study NCT05661708 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Chitosan
Description: Chitosan is a biodegradable, natural polyaminosaccharide with a nontoxic, non-allergenic, positively-charged polysaccharide derived from the deacetylation of chitin. Due to its molecular characteristics, chitosan has been used for improved hemostasis. Furthermore, chitosan has an antimicrobial and wound-healing effect
Study NCT06510595 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Active Treatment Arm
Description: Electrotherapy:~Transcutaneous Electrical Nerve Stimulation (TENS) will be placed across the fracture segments. The setting will be adjusted to 2±0.4 Hz sinusoidal wave, with a pulse width set between 50-200 microseconds, and each session will last between 20-30 minutes.~Active Elbow Flexion Exercise:~Following the electrotherapy session, the child will perform active assisted elbow flexion exercises with the forearm in a neutral position. This exercise will consist of 3 sets of 15 repetitions to enhance the role of the horizontal components of the brachioradialis muscle force.
Study NCT06510595 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Control Treatment Arm
Description: The child will wear a brace as a conservative treatment method.
Study NCT05742841 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: moderate- or high-intensity statin/ rosuvastatin
Description: moderate- or high-intensity statin (either rosuvastatin 10mg daily or rosuvastatin 40 mg daily)
Study NCT06438809 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Mesenchymal Stem Cells (MSCs)
Description: MSC suspension single does injection.
Study NCT05535985 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: acupuncture
Description: treatment of pain or disease by inserting the tips of needles at specific points on the skin
Study NCT05535985 — intervention group
Intervention type: DEVICE
Group type: PLACEBO_COMPARATOR
Intervention: placebo acupuncture
Description: placebo acupuncture
Study NCT06400589 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: tanfanercept
Description: TNF inhibitor
Study NCT06400589 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Vehicle
Description: Same composition as tanfanercept but without the active ingredient
Study NCT05063968 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: XZP-6019 tablet
Description: Tablet is administered orally once on Day 1 and Day 9, respectively
Study NCT05178381 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Continuous theta burst transcranial magnetic stimulation
Description: Participants will receive cTBS (50Hz stimulation at 80% AMT for 40 seconds). Stimulation will be applied to either the target area (frontal pole or IFG) or control area (vertex). Targeting of each region will be achieved using a frameless neuronavigation system with a Polaris Spectra infrared camera that enables stimulation to be centered on specific coordinates in Montreal Neurological Institute space. We will use coordinates \[x,y,z\] = \[35,50,15\] for frontal pole and \[x,y,z\] = \[56,16,22\] for right IFG based on the location of our activations in the young pilot group (Figure 4). The vertex control site is defined as the Cz position of a 10-20 EEG system. After receiving TMS, participants will stare at a white wall for 1 minute before performing the Horizon Task for 45 minutes.
Study NCT05217719 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: recombinant human thrombopoietin
Description: The dose of rhTPO is 15,000 U per day. The subcutaneous injection will be terminated when PCs are increased to normal. The duration of rhTPO will be 7 days.
Study NCT05217719 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: normal saline
Description: Patients in the control group will receive the same amount of saline as a placebo, which is injected subcutaneously. The duration of saline will be 7 days.
Study NCT04842565 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sintilimab
Description: Sintilimab (200mg ivdrip D1 Q3W)
Study NCT04842565 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: TACE
Description: TACE will be performed by clinical demand, the interval between two TACEs is not less than 4 weeks.
Study NCT06273930 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: 5% CALCIUM SODIUM PHOSPHOSILICATE
Description: Calcium sodium phosphosilicate is a particulate, bioactive glass material that degrades in the aqueous oral environment to release calcium and phosphate ions, leading to formation of hydroxycarbonate apatite on the dentine surface result in reduction in dentine hypersenstivity
Study NCT06273930 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: 8% Arginine
Description: Arginine contributes to Whole Mouth Health. It also plays a role with respect to dental caries, helping to maintain a pH-neutral environment, and is proven to rapidly help relieve dentin sensitivity. Arginine is truly a remarkable ingredient now being used in oral care products.
Study NCT04711616 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: physical therapy intervention
Description: physical therapy interventions include thermal therapy, electrical therapy, manual therapy, and therapeutic exercise.
Study NCT06483568 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Pathways to Happiness Intervention
Description: Four weeks of activities including a gratitude journal, random acts of kindness, self-compassionate letter, and capitalizing on positive events activities.
Study NCT06483568 — intervention group
Intervention type: BEHAVIORAL
Group type: SHAM_COMPARATOR
Intervention: Personal Organization Activities
Description: Four weeks of activities including a completed tasks journal, weekly task burst, productivity letter, and talking to others about task activities.
Study NCT05819723 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: CAM score
Description: The CAM scores assess the presence of delirium rapidly and accurately and also differentiates delirium from other cognitive impairment with a sensitivity of 94-100% and specificity of 90-95%.~It is an algorithm that consists of four features:~(i) Acute and fluctuating variation in mental status, (ii) Inattention, (iii) Incoherent or disorganized thinking, and (iv) Altered level of consciousness. CAM scores indicate delirium if the first two features are present and either the third or fourth feature is present.
Study NCT06405282 — intervention group
Intervention type: OTHER
Intervention: Manual Lymphatic Drainage
Description: MLD is a gentle manual technique used to decongest swollen areas and redirect lymphatic flow to non-congested areas
Study NCT05621122 — intervention group
Intervention type: OTHER
Intervention: This is an observational study
Description: This is an observational study. The control group (omnivours) will be compared with all otgher groups
Study NCT06405282 — intervention group
Intervention type: DEVICE
Intervention: Near infrared spectroscopy
Description: Oxygen saturation measurement
Study NCT06405282 — intervention group
Intervention type: DEVICE
Intervention: Temperature
Description: Thermal imaging
Study NCT06405282 — intervention group
Intervention type: DEVICE
Intervention: Tissue Dialectic Constant
Description: TDC captured by lymphatic fluid scanning device
Study NCT04961281 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Dexmedetomidine
Description: injection of Dexmedetomidine ( 10 microgram/kg) + 10 cc saline injection nearby median nerve as hydro-dissection
Study NCT04961281 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Triamcinolone
Description: injection of triamcinolone ( 40 mg) + 10 cc saline injection nearby median nerve as hydro-dissection
Study NCT05616546 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Influenza Vaccine
Description: The vaccine used in this study will be a licensed seasonal inactivated influenza vaccine for intramuscular injection that is approved by the FDA. Enrolled subjects will receive licensed seasonal inactivated influenza vaccine (administered as a part of the study).
Study NCT05063968 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Tablet is administered orally once on Day 1 and Day 9, respectively
Study NCT05063968 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: XZP-6019 tablet
Description: Tablet is administered fasted orally once on Day 1
Study NCT06105515 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Laparoscopic and Endoscopic Collaborative Surgery (LECS)
Description: Minimal invasive surgery in collaboration between endoscopy and laparoscopic surgery, to locally remove the tumor
Study NCT05063968 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: XZP-6019 tablet
Description: Tablet is administered after a high-fat meal orally once on Day 9
Study NCT06264908 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Integrated self-management programme
Description: 8 weeks integrated management programme with three educational sessions. Group therapy sessions (6-8 participants per group) delivered by occupational therapists and rheumatology nurses.~1. Disease pathology and Pain management~2. Joint protection and stretching exercise~3. Psychosocial education~4. Aids prescription Each session will consist of education session, exercise session and group sharing sessions.
Study NCT05178836 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: F520+F007
Description: Drug: F007~F007 is an antibody to CD20 molecules. One of the mechanisms of killing tumor cells is through antibody-dependent cell-mediated cytotoxicity (ADCC).~Drug: F520~F520 is a recombinant, humanized programmed death receptor-1 (PD-1) monoclonal antibody that binds to PD-1 and prevents binding of PD-1 with programmed death ligands 1 (PD-L1) and 2 (PD-L2).
Study NCT06467071 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: SH+ combined with a session for PMLD
Description: The intervention integrates WHO's Self Help Plus (SH+) and a session for Post-Migration Living Difficulties (PMLD) for Syrian women. SH+ is a guided self-help program with five weekly sessions led by facilitators, aimed at managing stress and psychological distress without requiring a diagnosis. This scalable intervention is based on solid research, proven effective in reducing stress and preventing mental health disorders (Tol et al., 2020; Turrini et al., 2019). The PMLD session, based on WHO's Problem Management Plus (PM+), involves focus groups to identify post-migration challenges. Participants share experiences, learn coping strategies, discover local resources, and strengthen social support networks. This integrated approach aims to enhance mental health, address post-migration difficulties, and improve stress reduction skills, supporting adaptation to a new country.
Study NCT05730868 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: myofascial release
Description: Soft tissue release will be performed on the trapezius, sub occipital and sternocleidomastoid muscles. The visual analog scale will be used to check pain intensity. Algometer will be used to check the pain pressure threshold and tissue hardness. neck disability index will be used to check neck disability
Study NCT05063968 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: XZP-6019 tablet
Description: Tablet is administered orally once daily for 14 Days continuously
Study NCT05063968 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Tablet is administered orally once daily for 14 Days continuously
Study NCT05192694 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: Computed tomography
Description: Positron Emission Tomography
Study NCT05134753 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Advanced PRF
Description: Advanced PRF will be placed for patients undergoing sinus augmentation
Study NCT05134753 — intervention group
Intervention type: BIOLOGICAL
Group type: PLACEBO_COMPARATOR
Intervention: Control
Description: PRF will be placed for patients undergoing sinus augmentation
Study NCT05033093 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Root Canal Sealants
Description: it is planned to conduct the research described below, on the effect of calcium silicate-based (iRoot SP), silicone-based (GuttaFlow Bioseal) and rezin-based (AH Plus) sealer on postoperative pain
Study NCT05730868 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: muscle energy technique
Description: Muscle energy Technique will be performed on the trapezius, sub occipital and sternocleidomastoid muscles. The visual analog scale will be used to check pain intensity. Algometer will be used to check the pain pressure threshold and tissue hardness. neck disability index will be used to check neck disability
Study NCT05730868 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: MFR & MET
Description: combination of myofascial release and muscle energy technique will be performed on the trapezius, suboccipital and sternocleidomastoid muscles. The visual analog scale will be used to check pain intensity. Algometer will be used to check the pain pressure threshold and tissue hardness. neck disability index will be used to check neck disability
Study NCT05730868 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: conventional therapy
Description: traditional physical therapy devices are used to relieve pain and spam. this will include a hot pack, ultrasound, and TENS (Transcutaneous electrical nerve stimulation)
Study NCT04789473 — intervention group
Intervention type: GENETIC
Intervention: Polygenic Risk Score Generation
Description: PRS will be calculated for gestational diabetes risk using both cohorts, participants wont have results returned to them during the study.
Study NCT05143567 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: standard of care anticoagulation in absence of thrombotic complications
Description: Subgroup IA - patients receive UFH (heparin, 7500 Units 2-3 times daily) for the prevention or treatment of VTE Subgroup IB - patients receive LMWH (enoxaparin) for the prevention or treatment of VTE Subgroup IC - patients receive oral anticoagulants (rivaroxaban 10mg QD) for the prevention or treatment of VTE
Study NCT05143567 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: standard of care anticoagulation in presence of thrombotic complications
Description: Subgroup IIA - patients receive UFH (heparin, 7500 Units 2-3 times daily) for the prevention or treatment of VTE Subgroup IIB - patients receive LMWH (enoxaparin, 0.4ml 2 times daily) for the prevention or treatment of VTE Subgroup IIC - patients receive oral anticoagulants (rivaroxaban 10mg QD) for the prevention or treatment of VTE
Study NCT04625101 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: NBI-827104
Description: Triple T-type calcium channel blocker.
Study NCT04625101 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Non-active dosage form.
Study NCT05143567 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: standard of care anticoagulation in combination with elastic compression
Description: Subgroup IIIA - patients receive UFH (heparin, 7500 Units 2-3 times daily) in combination with class II elastic compression (compression stockings above the level of the knee) for the prevention or treatment of VTE Subgroup IIIB - patients receive LMWH (enoxaparin, 0.4ml 2 times daily) in combination with class II elastic compression (compression stockings above the level of the knee) for the prevention or treatment of VTE Subgroup IIIC - patients receive oral anticoagulants (rivaroxaban 10mg QD) in combination with class II elastic compression (compression stockings above the level of the knee) for the prevention or treatment of VTE
Study NCT05400538 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Biorepair Toothpaste + Mousse
Description: Domiciliary application of the products twice a day.
Study NCT05400538 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Biorepair Toothpaste
Description: Domiciliary application of the product twice a day.
Study NCT04749043 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Oculus Quest 2 Virtual Reality Device
Description: 30 min VR experience exposure for labor analgesia. VR experiences include swimming in the ocean, walking through forests, engaging in 3D puzzles, exploring virtual lands, or interacting with musical objects
Study NCT04749043 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Nitrous oxide
Description: 30 min exposure for labor analgesia
Study NCT04558541 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Sensitivity to phonological rules
Description: Assess whether children with developmental language disorder (DLD) are sensitive to different phonological patterns that are predicted to align with development of morphosyntax or the lexicon; children with speech sound disorder (SSD) are not predicted to be sensitive to the same phonological patterns.
Study NCT04558541 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Sensitivity to semantic category cues.
Description: Assess whether all children, including those with DLD, show improved learning of OR rules when a semantic category cue is used.
Study NCT05954208 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Vısual Arts Group Therapy Based On Watson's Human Care Model
Description: VAGT-WHCM was applied to the intervention group, consisting of six sessions, lasting 90 minutes on average, once a week in three groups.
Study NCT05954208 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Ongoing treatment
Description: The control group participated only in the routine follow-up, treatment and practices in the institution.
Study NCT06227312 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: LADY 1 Pro, New Life Balance
Description: whole-body vibration training on the platform
Study NCT06227312 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: exercises
Description: calf raises and modified drop jumps
Study NCT06181838 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Lesion extraction
Description: Tretinoin and benzoil peroxide used concurent in both groups as standard therapy
Study NCT06181838 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Tretinoin
Description: Tretinoin and benzoil peroxide used concurent in both groups as standard therapy
Study NCT04983810 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fadraciclib
Description: Fadraciclib is a highly selective, orally- and intravenously- available, 2nd generation amino-purine inhibitor of CDK2 and CDK9.
Study NCT05079802 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Double antibiotic paste mixed with chitosan nanoparticles
Description: Lesion sterilization and tissue repair in non-vital primary molars with double antibiotic paste mixed with chitosan nanoparticles gel
Study NCT05079802 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Double antibiotic paste mixed with propylene glycol
Description: Lesion sterilization and tissue repair in non-vital primary molars with double antibiotic paste mixed with propylene glycol
Study NCT03441022 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Amiigo Watch Only
Description: Subjects will be asked to wear a wrist band with capabilities to detect their heart rate or rhythm on the basis of PPG on either wrist around the time of their cardioversion procedure. Data will be acquired from the wrist band at the same time as the electrocardiogram (ECG) monitor to which subjects are hooked up for the purposes of the cardioversion.
Study NCT03441022 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Amiigo Watch + BodyGuardian
Description: Subjects will be sent home after the cardioversion with a 30 day heart monitor called the BodyGuardian. This device continuously monitors their heart rate and rhythm and they will wear this on the chest. Subjects will also wear the wrist monitor over the same 30 day period.
Study NCT05521347 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: caffeine
Description: we employed a randomized crossover design to divide participants into a caffeine trial (CAF) and a placebo trial (PL). The CAF group took capsules with 3 mg/kg of caffeine, whereas the PL group took a placebo capsule. After a 1-h rest, the Stroop task, visual search ability test, and the shooting ability test were conducted.
Study NCT05521347 — intervention group
Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: caffeine
Description: we employed a randomized crossover design to divide participants into a caffeine trial (CAF) and a placebo trial (PL). The CAF group took capsules with 3 mg/kg of caffeine, whereas the PL group took a placebo capsule. After a 1-h rest, the Stroop task, visual search ability test, and the shooting ability test were conducted.
Study NCT06438094 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Root coverage surgery by means of a coronally advanced flap combined with a connective tissue graft
Description: A root coverage surgery will be performed using Zucchelli et al.'s coronally advanced flap combined with a connective tissue graft from the palate.
Study NCT06438094 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Reconstruction of the CEJ with a composite restoration followed by root coverage surgery by means of a coronally advanced flap combined with a connective tissue graft
Description: Reconstruction of the CEJ with a composite restoration will be performed in B+ and B- defects prior to root coverage surgery. A root coverage surgery will be performed using Zucchelli et al.'s coronally advanced flap combined with a connective tissue graft from the palate.